Microbiotica: Funding, Investors & Team (Oct 2026)
Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify and develop bacterial therapeutics and biomarkers. Their therapies accurately pinpoint gut bacteria associated with specific characteristics, allowing researchers to identify these traits before testing potential bacteria in advanced human models.
Microbiotica has raised $40.4M across 2 funding rounds on record, the most recent a Series C of $40.4M announced in Oct 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Microbiotica Company Profile and Key Stats
Latest funding round on record: Oct 2026.
Microbiotica Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Microbiotica announced an undisclosed round in Aug 2024; the amount was not disclosed.
2.2 years later, a Series C of $40.4M was announced in Oct 2026.
Microbiotica Investors
7 investors are recorded in total; the 5 named above are those the record identifies.
Microbiotica Founders and Leadership Team
Contact details for the Microbiotica team: 3 of 3 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Microbiotica Funding Compared to Other Biotechnology Startups
Microbiotica's latest round of $40.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Microbiotica in Biotechnology and Cambridge
Companies Similar to Microbiotica
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…
HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Microbiotica Funding FAQs
What does Microbiotica do?
Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify and develop bacterial therapeutics and biomarkers. Their therapies accurately pinpoint gut bacteria associated with specific characteristics, allowing researchers to identify these traits before testing potential bacteria in advanced human models.
How much funding has Microbiotica raised?
Microbiotica has raised $40.4M across 2 rounds on record. The most recent is a Series C of $40.4M announced in Oct 2026.
When did Microbiotica last raise funding?
Microbiotica's most recent funding round on record is a Series C of $40.4M, announced in Oct 2026.
Who has invested in Microbiotica?
Investors on record for Microbiotica include British Business Bank, Tencent, Seventure Partners, Cambridge Innovation Capital, IP Group. FundedIQ records 7 investors in total.
Who founded Microbiotica?
FundedIQ lists Mike Romanos (Founder) at Microbiotica.
Where is Microbiotica headquartered?
Microbiotica is based in Cambridge, Cambridgeshire, United Kingdom.
How many employees does Microbiotica have?
Microbiotica is in the 11-50 employee band.
When was Microbiotica founded?
Microbiotica was founded in 2016.
How does Microbiotica's funding compare to other Biotechnology startups?
Microbiotica's latest round of $40.4M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Microbiotica Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Microbiotica is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.